This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schuierer, M. M. Articles by Bosserhoff, A.-K. Search for Related Content PubMed PubMed Citation Articles by Schuierer, M. M. Articles by Bosserhoff, A.-K.

Reduction in Raf Kinase Inhibitor Protein Expression Is Associated with Increased Ras-Extracellular Signal-Regulated Kinase Signaling in Melanoma Cell Lines

¹ Institute of Pathology, Medical School of the University of Regensburg, Regensburg, Germany; ² Beatson Institute for Cancer Research, Cancer Research Campaign Beatson Laboratories, Bearsden, Glasgow, United Kingdom; and ³ Sir Henry Wellcome Functional Genomics Facility, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow, United Kingdom

Mutations in the Raf signaling pathway are known to play a pivotal role in the progression of malignant melanoma. In this study, we provide evidence that the Raf-1 kinase inhibitory protein (RKIP) and its effects on Raf-1-mediated activation of mitogen-activated protein/extracellular signal-regulated kinase kinase are important for the metastatic potential of malignant melanoma. Screening nine melanoma cell lines at mRNA and protein levels, we detected significant down-regulation of RKIP expression in comparison with normal melanocytes. Loss of RKIP expression in transformed cells in vivo was confirmed in immunohistochemical analyses demonstrating reduction of RKIP expression already in primary melanoma and even stronger down-regulation or complete loss in melanoma metastases. Stable transfection of the melanoma cell line Mel Im with an RKIP expression plasmid blocked the Raf kinase pathway, resulting in down-regulation of extracellular signal-regulated kinase 1/2 and activator protein 1 activity. In very good agreement with the in vivo finding that down-regulation of RKIP expression is most obvious in melanoma metastasis, overexpression of RKIP in the highly invasive Mel Im cell line leads to a significant inhibition of invasiveness in vitro. Taken together, our results suggest that loss of RKIP in malignant melanoma contributes to enhanced invasiveness of transformed cells and therefore to progression of the disease.

This article has been cited by other articles:

				A. Menoret, J. P. McAleer, S.-M. Ngoi, S. Ray, N. A. Eddy, G. Fenteany, S.-J. Lee, R. J. Rossi, B. Mukherji, D. L. Allen, et al. The Oxazolidinone Derivative Locostatin Induces Cytokine Appeasement J. Immunol., December 1, 2009; 183(11): 7489 - 7496. [Abstract] [Full Text] [PDF]

				R. M. Klein and A. E. Aplin Rnd3 Regulation of the Actin Cytoskeleton Promotes Melanoma Migration and Invasive Outgrowth in Three Dimensions Cancer Res., March 15, 2009; 69(6): 2224 - 2233. [Abstract] [Full Text] [PDF]

				A. E. Granovsky, M. C. Clark, D. McElheny, G. Heil, J. Hong, X. Liu, Y. Kim, G. Joachimiak, A. Joachimiak, S. Koide, et al. Raf Kinase Inhibitory Protein Function Is Regulated via a Flexible Pocket and Novel Phosphorylation-Dependent Mechanism Mol. Cell. Biol., March 1, 2009; 29(5): 1306 - 1320. [Abstract] [Full Text] [PDF]

				S.-Y. Shin, O. Rath, S.-M. Choo, F. Fee, B. McFerran, W. Kolch, and K.-H. Cho Positive- and negative-feedback regulations coordinate the dynamic behavior of the Ras-Raf-MEK-ERK signal transduction pathway J. Cell Sci., February 1, 2009; 122(3): 425 - 435. [Abstract] [Full Text] [PDF]

				H. Z. Li, Y. Wang, Y. Gao, J. Shao, X. L. Zhao, W. M. Deng, Y. X. Liu, J. Yang, and Z. Yao Effects of Raf Kinase Inhibitor Protein Expression on Metastasis and Progression of Human Epithelial Ovarian Cancer Mol. Cancer Res., June 1, 2008; 6(6): 917 - 928. [Abstract] [Full Text] [PDF]

				D. Chatterjee, E. Sabo, R. Tavares, and M. B. Resnick Inverse Association between Raf Kinase Inhibitory Protein and Signal Transducers and Activators of Transcription 3 Expression in Gastric Adenocarcinoma Patients: Implications for Clinical Outcome Clin. Cancer Res., May 15, 2008; 14(10): 2994 - 3001. [Abstract] [Full Text] [PDF]

				S. L. Fougner, J. Bollerslev, F. Latif, J. K. Hald, T. Lund, J. Ramm-Pettersen, and J. P. Berg Low Levels of Raf Kinase Inhibitory Protein in Growth Hormone-Secreting Pituitary Adenomas Correlate with Poor Response to Octreotide Treatment J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1211 - 1216. [Abstract] [Full Text] [PDF]

				F Al-Mulla, S Hagan, W Al-Ali, S P Jacob, A I Behbehani, M S Bitar, A Dallol, and W Kolch Raf kinase inhibitor protein: mechanism of loss of expression and association with genomic instability J. Clin. Pathol., April 1, 2008; 61(4): 524 - 529. [Abstract] [Full Text] [PDF]

				I. Zlobec, K. Baker, P. Minoo, J. R. Jass, L. Terracciano, and A. Lugli Node-Negative Colorectal Cancer at High Risk of Distant Metastasis Identified by Combined Analysis of Lymph Node Status, Vascular Invasion, and Raf-1 Kinase Inhibitor Protein Expression Clin. Cancer Res., January 1, 2008; 14(1): 143 - 148. [Abstract] [Full Text] [PDF]

				F. Al-Mulla, S. Hagan, A. I. Behbehani, M. S. Bitar, S. S. George, J. J. Going, J. J. C. Garcia, L. Scott, N. Fyfe, G. I. Murray, et al. Raf Kinase Inhibitor Protein Expression in a Survival Analysis of Colorectal Cancer Patients J. Clin. Oncol., December 20, 2006; 24(36): 5672 - 5679. [Abstract] [Full Text] [PDF]

				A. Calipel, F. Mouriaux, A.-L. Glotin, F. Malecaze, A.-M. Faussat, and F. Mascarelli Extracellular Signal-regulated Kinase-dependent Proliferation Is Mediated through the Protein Kinase A/B-Raf Pathway in Human Uveal Melanoma Cells J. Biol. Chem., April 7, 2006; 281(14): 9238 - 9250. [Abstract] [Full Text] [PDF]

				D. J. Panka, M. B. Atkins, and J. W. Mier Targeting the mitogen-activated protein kinase pathway in the treatment of malignant melanoma. Clin. Cancer Res., April 1, 2006; 12(7): 2371s - 2375s. [Abstract] [Full Text] [PDF]

				D. J. Panka, W. Wang, M. B. Atkins, and J. W. Mier The Raf Inhibitor BAY 43-9006 (Sorafenib) Induces Caspase-Independent Apoptosis in Melanoma Cells Cancer Res., February 1, 2006; 66(3): 1611 - 1619. [Abstract] [Full Text] [PDF]

				S. Hagan, F. Al-Mulla, E. Mallon, K. Oien, R. Ferrier, B. Gusterson, J. J. Curto Garcia, and W. Kolch Reduction of Raf-1 Kinase Inhibitor Protein Expression Correlates with Breast Cancer Metastasis Clin. Cancer Res., October 15, 2005; 11(20): 7392 - 7397. [Abstract] [Full Text] [PDF]

				T. Illmer, C. Thiede, A. Fredersdorf, S. Stadler, A. Neubauer, G. Ehninger, and M. Schaich Activation of the RAS Pathway Is Predictive for a Chemosensitive Phenotype of Acute Myelogenous Leukemia Blasts Clin. Cancer Res., May 1, 2005; 11(9): 3217 - 3224. [Abstract] [Full Text] [PDF]

				A. R. Jazirehi, S. Huerta-Yepez, G. Cheng, and B. Bonavida Rituximab (Chimeric Anti-CD20 Monoclonal Antibody) Inhibits the Constitutive Nuclear Factor-{kappa}B Signaling Pathway in Non-Hodgkin's Lymphoma B-Cell Lines: Role in Sensitization to Chemotherapeutic Drug-induced Apoptosis Cancer Res., January 1, 2005; 65(1): 264 - 276. [Abstract] [Full Text] [PDF]